Methicillin resistance in Staphylococcus aureus: A review of the molecular epidemiology, clinical significance and laboratory detection methods

West African Journal of Medicine

Volumn 28, Issue 5, 2009, Pages 281-290

  Taiwo, S S ^a  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Assessment; Diagnostic approaches; Epidemiology; Methicillin resistance; Molecular

Indexed keywords

AGAR; BETA LACTAM; CEFOXITIN; DALFOPRISTIN PLUS QUINUPRISTIN; GENE PRODUCT; GLYCOPEPTIDE; METICILLIN; NAFCILLIN; OFLOXACIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; RIFAMPICIN; VANCOMYCIN;

AFRICA; AGAR MEDIUM; AGGLUTINATION TEST; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BROTH DILUTION; CAUSE OF DEATH; CELL POPULATION; COMMUNICABLE DISEASE; DEVICE INFECTION; DIAGNOSTIC PROCEDURE; DIALYSIS; DISINFECTION; DISK DIFFUSION; DNA FINGERPRINTING; EPSILOMETER TEST; GENE CASSETTE; HAND WASHING; HEALTH HAZARD; HEALTH SERVICE; HEALTH SURVEY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INDWELLING CATHETER; INFECTION CONTROL; INSTRUMENT STERILIZATION; LABORATORY AUTOMATION; LONG TERM CARE; MEDLINE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; MORBIDITY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPIC VARIATION; PLASMID; PRESCRIPTION; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; RISK ASSESSMENT; STRAIN IDENTIFICATION;

BACTERIAL TYPING TECHNIQUES; DISEASE OUTBREAKS; DNA FINGERPRINTING; HUMANS; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; NIGERIA; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS;

EID: 76349101227     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Projan SJ, Novick RP. The molecular basis of pathogenicity. In: Crossley KB, Archer GL, eds. The staphylococci in human diseases, New York, Churchill Livingstone: 1997:55-81.
2. Jevon MP. 'Celbenin'-resistant staphylococci (letter). Br Med J 1961; 1: 24-25.
3. Parker MT, Hewitt MJH. Methicillin resistance in Staphylococcus aureus. Lancet. 1970; 1: 800-804.
4. Haley RW, Hightower AW, Khabbaz RF. The emergence of methicillin- resistant Staphylococcus aureus in United States hospitals. Ann Intern Med 1982; 97: 297-308.
5. Voss A, Doebbcling BN. The world wide prevalence of MRSA. Int J Antimicrob Agents. 1995; 5: 101-106
6. Sjostrom JE, Lofdahl S, Philipson L. Transformation reveals a chromosomal locus of the gene(s) for methicillin resistance in Staphylococcus aureus. J Bacteriol. 1975; 123: 905-915.
7. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec (SCCmec), encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2000; 44: 1548-1555.
8. Hartman BJ, Tomasz A. Low-affinity penicillin-binding proteins of â-lactam resistance in Staphylococcus aureus. J Bacteriol. 1984.; 158: 513-516.
9. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet. 2001; 357: 1225-1240.
10. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance System report, data summary from January 1990 - May 1999. Am J Infect Control. 1999; 27: 520-532.
11. Watanakunakorn C. Treatment of infections due to MRSA. Ann Intern Med. 1982; 94: 785-788.
12. Saravolatz LD, Pohlod DJ, Arking LM. Community acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med. 1982; 97: 325-329.
13. Centers for Disease Control and Prevention. Four paediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR Morb. Mortal. Wkly. Rep. 1999; 48: 707-710.
14. Lindenmayer JM. Schoenfeld S, O'Grady R, Carney JK. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and surrounding community. Arch Intern Med. 1998; 158: 895-899.
15. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 15th informational supplement M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA, 2005.
16. Skov R, Smyth R, Larsen AR, BolmstrÔm A, Karlsson A, Mills K, et al. Phenotypic detection of methicillin resistance in Staphylococcus aureus by disk diffusion testing and E-test on Mueller-Hinton agar. J Clin Microbiol. 2006; 44: 4395-4399.
17. Skov R, Palleson LV, Poulsen RL, Espersen F. Evaluation of 3 new hours hybridization method for detection of the mecA gene in Staphylococcus aureus and the correlation to existing genotypic and phenotypic susceptibility testing methods. J Antimicrob Chemother. 1999; 43: 467-475.
18. Shopsin B, Kreiswirth BN. Molecular epidemiology of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis. 2001; 7: 323-326.
19. Bell JM, Turnidge JD. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program 1998-1999. Antimicrob Agents Chemother. 2002; 46: 879-881.
20. American Journal of Infection Control. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control. 2002; 30: 458-475.
21. Hiramatsu K, Hanaki H, Ito T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997; 40: 135-136.
22. Ploy MC, Grelaud C, Martin C, de Lumley L, Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital (letter). Lancet. 1998; 351: 1212.
23. Smith TL, Pearson ML, Wilcox KR. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med. 1999; 340: 493-501.
24. Michigan Department of Community Health (MDCH). Second Michigan VRSA case: 3 March 2005. [Online] http://www.michigan.gov/documents/VRSA-Feb05- 118391-7.pdf
25. Olayinka BO, Olayinka AT, Onaolapo JA, Olurinola PF. Pattern of resistance to vancomycin and other antimicrobial agents in staphylococcal isolates in a University Teaching Hospital. Afr J Clin Exper Microbiol. 2005; 6: 21-27.
26. Onolitola OS, Olayinka BO, Salawu MJ, Yakubu SE. Nasal carriage of methicillin-resistant Staphylo-coccus aureus with reduced vancomycin susceptibility (MRSA-RVS) by healthy adults in Zaria, Nigeria. J Trop Microbiol Biotechnol. 2007; 3: 19-22.
27. Rotimi VO, Orebanjo O, Banjo TO, Nwobu R, Onyenefa PI. Occurrence and antibiotic susceptibility profile of methicillin-resistant Staphylococcus aureus in LUTH Lagos. Centr Afr J Med. 1987; 33: 95-98.
28. Okesola AO, Oni AA, Bakare RA. Prevalence and antibiotic suscepti-bility pattern of MRSA in Ibadan, Nigeria. J Hosp Infect. 1999; 41: 74-75.
29. Ikeh EI. Methicillin-resistant Staphylococcus aureus (MRSA) at Jos University Teaching Hospital. Afr J Clin Exper Microbiol. 2003; 4: 52-55.
30. Taiwo SS, Onile BA, Akanbi II AA. Methicillin-resistant Staphylococcus aureus (MRSA) isolates in Ilorin. Afr J Clin Exper Microbiol. 2004; 5: 189-197
31. Taiwo SS, Fadiora SO, Fayemiwo SA. High antimicrobial resistance among bacterial isolates of blood stream infections in a Nigerian University Teaching Hospital. World J Microbiol Biotechnol. 2008; 24: 231-236.
32. Matsuhashi M, Song MD, Ishino F. Molecular cloning of the gene of a penicillin binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus. J Bacteriol. 1986; 167: 975-980.
33. Kreiswirth B, Kornblum J, Arbeit RD, Eisener W, Maslow JN, McGeer A, et al. Evidence for clonal origin of methicillin resistance in Staphylococcus aureus. Science. 1993; 259: 227-230.
34. Chongtrakool P, Ito T, Ma XX, Kondo Y, Trakulsomboon S, Tiensasitorn C, et al. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob. Agents Chemother. 2006; 50: 1001-1012.
35. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteraemia: a meta analysis. Clin. Infect. Dis. 2003; 36: 53-59.
36. Perovic O, Koonrnhof H, Black V, Moodley I, Duse A, Galpin J. Staphylococcus aureus bacteraemia in two academic hospitals in Johannesburg. South Afr Med J. 2006; 96: 714-717.
37. Rubin RJ, Harrington CA, Poon A, Dietrich A, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis. 1999; 5: 9-17.
38. Johnson JK, Khole T, Shurland S, Kreisel K, Stine CO, Roghmann M. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone. Emerg Infect Dis. 2007; 13: 1195-1200.
39. Thornsberry C, Caruthers JQ, Baker CN. Effect of temperature on the in vitro susceptibility of Staphylococcus aureus to penicillinase-resistant penicillins. Antimicrob Agents Chemother. 1973; 4: 263-269.
40. Boyce JM. Re-evaluation of the ability of the standardized disk diffusion test to detect methicillin-resistant strains of Staphylococcus aureus. J Clin Microbiol. 1984; 19: 813-819.
41. McDougal LK, Thornsberry C. The role of β-lactamase in staphylococcal resistance to penicillinase-resistant penicillin and cephalosporin. J Clin Microbiol. 1986; 23: 832-839.
42. Putland RA, Guinness MDG. Autobac susceptibility testing of methicillin-resistant and susceptible Staphylo-coccus aureus isolated in an Australian hospital. J Clin Microbiol. 1985; 22: 822-827.
43. Struelens MJ. Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin Microbiol Infect. 1996; 2: 2-11.
44. Zuccarelli AI, Roy I, Harding GP. Diversity and stability of restriction enzyme profiles of plasmid DNA from methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 1990; 28: 97-102.
45. Taiwo SS, Bamidele M, Omonigbehin EA, Akinsinde KA, Smith SI, Onile BA, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Ilorin, Nigeria. West Afr J Med. 2005; 24: 100-106.
46. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulse field gel electrophoresis: criteria for bacterial typing. J Clin Microbiol. 1995; 33: 2233-2239.
47. Chung MH, de Lencastre P, Matthews P, Tomasz A, Adamsson I, Aries de Sousa M, et al. Molecular typing of methicillin-resistant Staphylococcus aureus by pulse field gel electro-phoresis: comparison of results obtained in a multi-laboratory effort using identical protocols and MRSA strains. Microb Drug Resist. 2000; 6: 189-198.
48. Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG. Multilocus Sequence Typing for characterization of Methicillin-Resistant and Methicillin-Susceptible clones of Staphylococus aureus. J Clin Microbiol. 2000; 38: 1008-1015.
49. Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M. Dodge DE, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol. 1999; 37: 3556-3563.
50. Cookson BD, Robinson DA, Monk AB, Murchan S, Deplano A, Ryck R, et al. Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. J Clin Microbiol. 2007; 45: 1830-1837.